TYPE-II DIABETES - SEARCH FOR PRIMARY DEFECTS

被引:8
|
作者
TURNER, R
HATTERSLEY, A
COOK, J
机构
[1] The Diabetes Research Laboratories, Radcliffe Infirmary, Oxford
关键词
TYPE-2; DIABETES; INHERITANCE; PATHOPHYSIOLOGY; GENE MUTATIONS;
D O I
10.3109/07853899209167004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes is a familial disease, but recent analysis of nuclear families indicates it is unlikely to be due to a single dominant gene with high penetrance and that it could be polygenic. Insulin resistance is a major feature, with obesity being a major determinant. Beta cell deficiency is a sine qua non of Type 2 diabetes. It is possible that obesity, insulin resistance independent from obesity and impaired beta cell function are independently inherited factors. None of these can be said to be 'primary' as diabetes usually results from the interaction of several geometric and environmental factors. This makes linkage analysis of Type 2 diabetes of uncertain benefit, since heterogeneity can occur within a pedigree. The only mutation so far discovered is of glucokinase producing maturity-onset diabetes of the young, that has a clearly defined and unusual phenotype. Identification of genes that cause classical Type 2 diabetes is likely to come from population association studies, molecular scanning techniques and direct sequencing of candidate genes rather than linkage analysis.
引用
收藏
页码:511 / 516
页数:6
相关论文
共 50 条
  • [1] THE GENETICS AND PATHOPHYSIOLOGY OF TYPE-II AND GESTATIONAL DIABETES
    CSORBA, TR
    EDWARDS, AL
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1995, 32 (5-6) : 509 - 550
  • [2] TYPE-I AND TYPE-II DIABETES
    SCHERBAUM, WA
    MEDIZINISCHE WELT, 1991, 42 (11): : 911 - 913
  • [3] REGIONAL FAT DISTRIBUTION - IMPLICATIONS FOR TYPE-II DIABETES
    BJORNTORP, P
    INTERNATIONAL JOURNAL OF OBESITY, 1992, 16 : S19 - S27
  • [4] LIVER GLUCOKINASE - DECREASED ACTIVITY IN PATIENTS WITH TYPE-II DIABETES
    CARO, JF
    TRIESTER, S
    PATEL, VK
    TAPSCOTT, EB
    FRAZIER, NL
    DOHM, GL
    HORMONE AND METABOLIC RESEARCH, 1995, 27 (01) : 19 - 22
  • [5] Correlation of Albuminuria and Diabetic Retinopathy in Type-II Diabetes Mellitus Patients
    Dash, Shovna
    Chougule, Abhilash
    Mohanty, Soumyakanta
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [6] POLYMORPHONUCLEAR LEUKOCYTE DEFORMABILITY IN TYPE-II DIABETES-MELLITUS AND IN AGING
    MISSIRLIS, Y
    KALERIDIS, V
    CLINICAL HEMORHEOLOGY, 1994, 14 (04): : 489 - 495
  • [7] THE KEY ROLE OF ISLET DYSFUNCTION IN TYPE-II DIABETES-MELLITUS
    PORTE, D
    KAHN, SE
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1995, 18 (04): : 247 - 254
  • [8] IMPORTANCE OF FAMILY SUPPORT IN THE METABOLIC CONTROL OF PATIENTS WITH TYPE-II DIABETES
    VALADEZFIGUEROA, ID
    ALDRETERODRIGUEZ, MG
    ALFAROALFARO, N
    SALUD PUBLICA DE MEXICO, 1993, 35 (05): : 464 - 470
  • [9] CORRELATES OF HYPOGLYCEMIC FEAR IN TYPE-I AND TYPE-II DIABETES-MELLITUS
    POLONSKY, WH
    DAVIS, CL
    JACOBSON, AM
    ANDERSON, BJ
    HEALTH PSYCHOLOGY, 1992, 11 (03) : 199 - 202
  • [10] GSK-3 Inhibitors as New Leads to Treat Type-II Diabetes
    Srivani, Gowru
    Sharvirala, Ramyakrishna
    Veerareddy, Prabhakar Reddy
    Pal, Dilipkumar
    Kiran, Gangarapu
    CURRENT DRUG TARGETS, 2021, 22 (13) : 1555 - 1567